StockData
Longeveron Inc. logo

Longeveron Inc. (LGVN) stock

LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.92−0.19 (-9.00%)

Close on Nov 18, 2026Market cap $61.21MP/E –Yield –

Longeveron total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Longeveron's total debt was $5.00K at Sep 30, 2021. For fiscal 2020 it was $139.00K.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$139.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2021Sep 30, 2021$5.00K–
Q2 FY2021Jun 30, 2021$5.00K–
Q1 FY2021Mar 31, 2021$4.01K–
Q4 FY2020Dec 31, 2020$139.00K–

More Longeveron figures

See a number that looks wrong?